Neoantigen vaccine-induced tumor-specific T-cell injection
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Neoantigen vaccine-induced tumor-specific T-cell injection, covering 2026-02-12 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer [Phase 1]